DeepMind Launches Antigravity Platform to Accelerate Antimicrobial Peptide Discovery
Current overview (not historical)
Google DeepMind has unveiled the Antigravity platform, a new tool that integrates the ProtNLM model to predict biological functions directly from amino‑acid sequences. The platform is designed to speed up the discovery of antimicrobial peptides (AMPs) by allowing researchers to set specific targets and search for novel candidates within the Streptococcus pneumoniae genome. Antigravity also offers an agentic science workbench that assists users in identifying, structurally evaluating, and prioritizing potential AMP candidates. This initiative aims to streamline the early stages of AMP research and bring promising therapeutics closer to clinical application.
Written with AI from the reporting · updated 10/15/2026
Expand the detailed fact route and sources
Story route
A station-by-station route from the first public evidence onward; every station carries its own evidence and uncertainty.
- 1Unclassified fact stationOct 15, 00:00recorded Oct 16, 00:50single sourcerevised
使用 Google Antigravity 发现新型抗菌肽候选物
Read original source ↗ Google DeepMindReplay this moment in the explorerEvidence & revisions · 1 source records
- Subject:
- Action:
- 展示如何使用 Google Antigravity 发现抗菌肽候选物
- Object:
- 抗菌肽候选物
- Occurred (fact side):
- Oct 15, 00:00
- Published (valid side):
- Oct 16, 00:08
- First seen (known side):
- Oct 16, 00:50
Fact stationSingle source · one-sided claimRevisedCopy may have been revised later; time replay is bounded. Layer labels group reading only, not causation between layers.
Uncertainty marks flag where to check the sources; they are not proven causation.
Report timeline
Explore every side through dated source reports.
- Google DeepMindFirst-party sourceRelated fact: single sourceSource report revisedGoogle DeepMind uses Antigravity platform to accelerate discovery of novel antimicrobial peptides
Report first recorded Oct 16, 00:50
Google DeepMind's agentic development platform, Google Antigravity, integrates ProtNLM, a deep learning model that predicts biological function from amino acid sequences, to help researchers scan millions of uncharacterized proteins in the UniProt database. Researchers used this platform to uncover a novel antimicrobial peptide candidate with predicted activity against pathogens causing respiratory tract infections, which is now undergoing wet-lab validation.
Read original source ↗
Event discussion
Reader opinions are hosted on GitHub Discussions; posting requires a GitHub account. Comments are not verified facts.